FDA Expands Eligibility for COVID-19 Vaccine Boosters
Ages 18 and Older Can Now Receive Single Booster Dose
CORPUS CHRISTI, TX – Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing the use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 vaccine.
The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices will meet later today to discuss further clinical recommendations.
Today’s action expands the use of booster doses of both vaccines to include all individuals 18 years of age and older at least six months after completion of the primary vaccination series of the Moderna COVID-19 Vaccine or Pfizer-BioNTech COVID-19 Vaccine or at least two months after completion of primary vaccination with the Johnson & Johnson COVID-19 Vaccine.
Current booster guidance for all vaccines is:
- All adults who received a Pfizer or Moderna COVID-19 vaccine are eligible for a booster shot at six months or more after their initial series.
- For those adults who got the single-shot Johnson & Johnson vaccine, a booster shot is recommended after two months.
- Eligible individuals may choose which vaccine they receive as a booster dose. Some may prefer the vaccine type they originally received or may decide to get a different booster.
For more information, go to Coronavirus (COVID-19) Update: FDA Expands Eligibility for COVID-19 Vaccine Boosters | FDA